Oxford vaccine doing 'everything expected': Study

The Oxford University COVID-19 vaccine undergoing Phase III clinical trials with British pharma giant AstraZeneca is doing 'everything expected' which means good news in the fight against the......

Oxford varsity enrols volunteers for Covid vaccine trial

Scientists from the University of Oxford have opened up their COVID-19 vaccines for clinical trial recruitments as part of a 'rapid vaccine response' to the coronavirus pandemic. The trial, a......

Oxford vaccine safe, Indian trials going on smoothly: Serum Institute

Vaccine major Serum Institute of India on Thursday said the COVID-19 vaccine developed by AstraZeneca and Oxford University is safe and effective, and the Indian trials are progressing smoothly......

India will wait for DCGI nod to restart Oxford vaccine trial

The global trials were halted after a study participant suffered a ‘potentially unexplained illness', reports Sohini Das. IMAGE: Serum Institute of India is the Indian partner of AstraZeneca......

Meet Adar Poonawala, India's COVID-19 vaccine man

Serum Institute is investing $200 million to create capacities for the COVID-19 vaccine.Sohini Das profiles its 39-year-old CEO. IMAGE: Adar Poonawalla, right, and his father Dr Cyrus S......

Serum Institute's race to produce COVID-19 vaccine

'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'Ritwik Sharma reports. IMAGE: A quality control test conducted at the Serum......

'We will price Covid vaccine below Rs 1,000'

'Once the trials are successful in India and the UK, we are certain that COVISHIELD will be one of the first vaccines to be introduced.' IMAGE: The Reference Center for Special Immunobiologicals......

Serum Institute to produce COVID-19 vaccine by yearend

'The challenge will be making sure its efficacy is high.''If a vaccine is only 50 to 60 per cent efficient, it's a double-edged sword.' Adar Poonawalla, chief executive officer, Serum Institute of......